Aviso Wealth Management’s AbbVie ABBV Stock Holding History

Aviso Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.21M	Buy	19,378 +648	+3%	+$144K	1.9%	13
2025 Q4	$4.28M	Buy	18,730 +455	+2%	+$104K	1.8%	13
2025 Q3	$4.23M	Buy	18,275 +494	+3%	+$101K	1.84%	13
2025 Q2	$3.3M	Buy	17,781 +1,089	+7%	+$202K	1.54%	16
2025 Q1	$3.5M	Buy	16,692 +2,317	+16%	+$450K	1.86%	10
2024 Q4	$2.55M	Buy	14,375 +3,719	+35%	+$684K	1.3%	13
2024 Q3	$2.1M	Sell	10,656 -569	-5%	-$106K	1.14%	21
2024 Q2	$1.93M	Sell	11,225 -1,499	-12%	-$248K	1.14%	17
2024 Q1	$2.32M	Buy	12,724 +962	+8%	+$166K	1.46%	11
2023 Q4	$1.82M	Buy	+11,762	New	+$1.71M	1.32%	17

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aviso Wealth Management's ABBV Position: Q1 2026 in Review

Aviso Wealth Management increased its AbbVie (ABBV) stake by 3.5% in Q1 2026, buying an estimated $144K and bringing the position to 19,378 shares worth $4.21M. The position accounts for 1.9% of the portfolio, ranked #13.

Aviso Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.28M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Aviso Wealth Management held 19,378 shares of AbbVie worth $4.21M as of Q1 2026.
Aviso Wealth Management bought 648 AbbVie shares in Q1 2026, an estimated $144K.
AbbVie made up 1.9% of Aviso Wealth Management's portfolio in Q1 2026, its #13 holding.
Aviso Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Aviso Wealth Management's AbbVie position peaked at $4.28M in Q4 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Aviso Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.